Media Release Copenhagen, Denmark and Lausanne, Switzerland, October 30, 2020

See more here:
Genmab and ADC Therapeutics Announce Amended Agreement for Camidanlumab Tesirine (Cami)

Preprint article details research conducted at George Mason’s Regional Biocontainment Laboratory:

Go here to see the original:
Innovation Pharmaceuticals and George Mason University Announce Public Release of Laboratory Testing Results Demonstrating Brilacidin’s COVID-19...

– Lead product candidate, SB206 currently being evaluated in B-SIMPLE4 pivotal Phase 3 study in molluscum contagiosum with topline data targeted for Q2 2021 –

Original post:
Novan Reports Third Quarter 2020 Financial Results and Provides Corporate Update

--OLINVYK commercial supply on track and available in November

Here is the original post:
Trevena, Inc. Announces DEA Scheduling of OLINVYK™ (oliceridine) injection

NEEDHAM, Mass., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA) today recognizes Acromegaly Awareness Day, which is observed every year on November 1, and reiterates its commitment to people with acromegaly and the patient advocacy groups in their ongoing efforts to increase awareness of acromegaly and support the unique needs of people living with acromegaly.

Excerpt from:
Chiasma Reinforces Commitment to People with Acromegaly and Advocacy Organizations on Acromegaly Awareness Day

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (Nasdaq/AIM: HCM) today announces that Mr. Christian Hogg, Chief Executive Officer of Chi-Med, will present or participate in the following virtual conferences:

Read the original here:
Chi-Med to Attend Upcoming Industry and Investor Virtual Conferences

CAMBRIDGE, Mass., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that it will report third quarter 2020 financial results and provide a corporate update before market open on Friday, November 6, 2020. Jounce Therapeutics’ management team will host a live conference call and webcast at 8:00 a.m. ET.

See more here:
Jounce Therapeutics to Announce Third Quarter 2020 Financial Results and Host Conference Call on Friday, November 6, 2020

SANTA MONICA, Calif., Oct. 30, 2020 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for liver disease, today announced an interview with Terren Peizer, Chairman and Chief Executive Officer, will air on The RedChip Money Report television program this Sunday November 1st. The RedChip Money Report airs in 100 million homes on Sundays at 6 p.m. local time in every country in Europe on Bloomberg International.

Read more here:
BioVie Interview to Air on Bloomberg International on the RedChip Money Report

SOUTH SAN FRANCISCO, Calif., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that it has dosed its first subject in a first-in-human Phase 1a/b clinical trial, ALG-000184-201 (NCT04536337). The study will evaluate ALG-000184, a small molecule class II capsid assembly modulator (CAM) that targets hepatitis B virus (HBV) capsid assembly as well as the establishment of covalently closed circular DNA (cccDNA).

View post:
Aligos Therapeutics Doses First Subject in Phase 1 Proof-of-Concept Study of Small Molecule Drug Candidate ALG-000184 for Chronic Hepatitis B

RESEARCH TRIANGLE PARK, N.C., Oct. 30, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted oral, once-daily berotralstat a positive scientific opinion through the Early Access to Medicines Scheme (EAMS).

Read the original here:
MHRA Grants HAE Patients Early Access to BioCryst’s Berotralstat in United Kingdom

PORTLAND, Ore., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Nobilis Therapeutics, a late stage biotechnology company that is developing a drug-device combination for treatment of psychiatric disorders will present at the virtual CapCon 2020 Venture Conference, Nov 16-17.

Visit link:
Nobilis Therapeutics to Present at CapCon 2020 Venture Conference

-Dr. Tamera Coyne-Beasley, MD, MPH, FAAP, FSAHM is the Derrol Dawkins, MD Endowed Chair in Adolescent Medicine at Children’s of Alabama, Professor of Pediatrics and Internal Medicine, Director of the University of Alabama at Birmingham Division of Adolescent Medicine, and Vice Chair of Pediatrics for Community Engagement

See the original post here:
Generex Subsidiary NuGenerex Immuno-Oncology Announces Appointment of Dr. Tamera Coyne-Beasley to the Scientific Advisory Board for its COVID-19...

Originally posted here:
BioFlorida Names AIM ImmunoTech CEO Thomas K. Equels as Entrepreneur of the Year

SUWON, Republic of Korea, Oct. 30, 2020 (GLOBE NEWSWIRE) -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application to evaluate the efficacy of OLX10010 as an adjunct therapy to reduce the recurrence of hypertrophic scars after scar revision surgery.

Go here to see the original:
OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the Efficacy of OLX10010 in Phase 2a Clinical Trial for Hypertrophic Scars

Medical skin care products are used for beautifying or to address some other skin care problems. The cosmetic industry is booming and skin care forms a very huge part of this industry. The aesthetic appearance is so important that people spend a lot on skin care products and treatment. People being more technologically aware of the various new skin care products trending in the market. In addition to the aesthetic application, the medical skin care products are also used to address issues such as acne, pimples or scars.

Medical Skin Care Products Market: Drivers and Restraints

The medical skin care products is primarily driven by the need of natural based active ingredients products which are now trending in the market. Consumers demand medical skin care products which favor health and environment. Moreover, the consumers are updated with the trends so that various companies end up providing such products to satisfy the customers. For instance, a single product face mask has thousands of different variants. This offers consumers different options to select the product depending on the skin type. Moreover, the market players catering to the medical skin care products are offering products with advanced technologies. For instance, Santinov launched the CICABEL mask using stem cell material based on advanced technologies. The stem cells used in the skin care product helps to to protect and activate the cells and promote the proliferation of skin epidermal cells and the anagenesis of skin fibrosis.

To remain ahead of your competitors, request for a sample[emailprotected]

https://www.persistencemarketresearch.com/samples/18469

Medical Skin Care Products Market: Segmentation

On the basis of product type the medical skin care products market can be segmented as:

On the basis of application, the medical skin care products market can be segment as:

On the basis of distribution channel, the medical skin care products market can be segment as:

Medical Skin Care Products Market: Overview

Medical skin care products are used to address basic skin problems ranging from acne to scars. There are various advancements in the ingredients used to offer skin care products to the consumers. For instance, the use of hyaluronic acid and retinoids is the latest development in the industry. The anti-aging creams are at the forefront as the help treating issues such as wrinkles, scars, acne, and sun damage. Another, product in demand is the probiotic skincare which include lactobacillus and bifidobacterium.

To receive extensive list of important regions, Request Methodology here @

https://www.persistencemarketresearch.com/methodology/18469

Medical Skin Care Products Market: Region-wise Outlook

In terms of geography, medical skin care products market has been divided into five regions including North- America, Asia- Pacific, Middle-East & Africa, Latin America and Europe. North America dominated the global medical skin care products market as international players are acquiring domestic companies to make their hold strong in the U.S. LOral is accelerating its U.S. market by signing a definitive agreement with Valeant Pharmaceuticals International Inc. to acquire CeraVe, AcneFree and Ambi skin-care brands for US$ 1.3 billion. The acquisition is expected LOreal to get hold of the brands in the price-accessible segment. Asia Pacific is expected to be the fastest growing region owing to the increasing disposable income and rising awareness towards the skin care products.

Medical Skin Care Products Market: Key Market Participants

Some of the medical skin care products market participants are Avon Products Inc., Beiersdorf AG, Colgate-Palmolive Company, Kao Corporation, LOral S.A., Procter & Gamble, Shiseido Company, The Estee Lauder Companies Inc., Unilever PLC, Revlon, Clinique Laboratories, llc., Murad, LLC., SkinCeuticals, RMS Beauty, J.R. Watkins and 100% PURE.

You Can Request for TOC Here @https://www.persistencemarketresearch.com/toc/18469

Explore Extensive Coverage of PMR`s

Life Sciences & Transformational HealthLandscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Naved BegPersistence Market ResearchAddress 305 Broadway, 7th Floor, New York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Websitehttps://www.persistencemarketresearch.com

Read the rest here:
The Medical Skin Care Products market to grow on a prudent note from 2017 to 2025 - TechnoWeekly

(Image: Sunny Ng/Unsplash) By Chloe Pek October 30, 2020

Thanks to epigenetic research, it turns out that 70 to 75 per cent of skin ageing is up to your environment and lifestyle, instead of genes. We ask Prof Augustinus Bader, co-founder of his eponymous skincare brand, and Dr Nadine Pernodet, Este Lauder's vice president of Skin Biology and BioActives more

Sign up for our newsletters to get all our top stories delivered.

You've Successfully Subscribed

Heres a piece of good news and not so great news. Thanks to epigenetic research, studies have found that while genes play a role in your skin type and how it ages, 70 to 75 per cent of skin ageing is actually dependent of environment and lifestyle factors. The goodyou have a chance at achieving youthful skin. The badyoull have to put in some extra effort for it.

Epigenetics refers to modifications that change the expression of genes but do not directly alter the DNA sequence. The science of epigenetics shows that factors such as environment and lifestyle can change your gene expression, Dr Nadine Pernodet, vice president of Skin Biology & BioActives at the Este Lauder Companies, explains.

(Related: Glow Recipe in Singapore: The Founders Reveal How To Achieve Glass Skin and More)

The genes in your skin are set. You were born with it, and it is a given, but you caninfluence them, says Prof Augustinus Bader, founder of his eponymous skincare brand.

Lifestyle factors, such as what youeat, where you live, when yousleep, how youexercise, evenageingcan eventually cause chemical modifications around the genes that will turn those genes on or off over time.

Though cell care isnt a new concept, it has increasingly taken centre stage in the skincare industry in recent years.

Este Lauder most recently reformulated its well-loved Advanced Night Repair Serum, boasting a new Chronolux Power Signal Technology that is powered by a proprietary blend of New Adansonia digitata extract and other plant-derived ingredients to boost cellular communication.

Through seven years of research, Este Lauder has proved for the first time that a specific micro-signalling molecule is essential to the skins natural repair and promotes multiple vital anti-ageing pathways.

Significantly, this molecule, helps skin increase its natural renewal of fresh cells and boosts its natural collagen production, Dr Pernodet shares.

Hollywood favourite Augustinus Bader, whose star product is The Cream, has also always been informed by cellular science since its founding. The brand officially launched in Singapore in September.

Our skincare technology works with the skin's own intrinsic repair needs by delivering various active ingredients that control and influence the skin cells in a targeted manner. This combination of active ingredients makes up our proprietary Trigger-Factor Complex 8 (TFC8), Prof Bader shares.

TFC8 functions like GPS: utilising a novel transporting mechanism made up of ceramide structures to deliver these nutrient compounds to the right location within the skin cell microenvironment. In short, the cream naturally causes the skin to undergo a physiological process of remodelling. When you can do that, you can influence epigenetic factors that enable the body to fix your skin according to your own needs.

We find out more from both experts about skin ageing, and how to optimise your environment and lifestyle for a more youthful complexion.

(Related: Celebrity Facialist Joanna Czech Shares Her Self-Care Routine and Tips to Prevent Maskne)

Signs of ageing skin is mainly characterised by dryness, dullness, lack of elasticity, and fine lines. According to Dr Pernodet, this can be influenced by the environment, such as UV and blue light, pollution and ozone, travel, and varied climates as well as lifestyle choices, like diet and sleep patterns.

Environmental factors such as UV and blue light exposure and pollution can result in oxidative stress on the skin, manifesting as wrinkles, roughness, pigmentation, and yellowish or greyish-yellow complexion.

Diets heavy in fat, tobacco, alcohol, sugar and baked goods can also compromise the skins barrier function, cause skin inflammation, and affect its lipid composition.

The skin completely renews itselfapproximately every 27 days. Since our skin is living tissue, it is also not a permanentstructure; it is nourished and rebuilt every day. This rebuilding is called remodelling, Prof Bader explains.

Ageingcorrelates with a lack of elasticity due to a different form of remodelling of the skin over time.Positively rebuilding our skin can be achieved by returningessential components to the cells of our skin.

The cells can then follow their natural role of rebuilding the skin in a healthy way, gradually replacing hardened forms of collagens in aged skin with elastin.

(Related: Biohack Your Way To Beauty And Health Using Your DNA And Stem Cells At These Wellness Retreats Around The World)

We often hear about the term circadian rhythm, and its more than just a body clock that determines when you wake up or sleep. As every cell in our body has a circadian rhythm, it can impact everything from our hormones and moods to our skin.

This means that different processes are occurring to your skin at different periods of the day, making them more susceptible to certain types of skincare at each period.

According to both Prof Bader and Dr Pernodet, night time is when the skins natural process is at its peak, and its barrier becomes more permeable for products to absorb effectively.

Nighttime is when the skins moisture barrier is at its thinnest, causing the most moisture loss. Dehydration can also accelerate skin damage. That is why hydration is so critical before bed to creating the optimal environment for skin to maximise its natural nightly repair of visible skin damage, Dr Pernodet advises. The Este Lauder Advanced Night Repair Synchronised Multi-Recovery Complex includes a high level of hyaluronic acida moisture magnetthat promises to offer 72 hours of hydration. The night serum also offers eight hours of antioxidant power.

Products rich in antioxidants defend skin against further trauma from free radical damage and oxidative stress, which helps to improve signs of ageing.

Life inflicts little traumas on the skin all the time. Your stem cells are there to heal these traumas. As you get older, your skin becomes less adept at healing itself, instead often favouring scarringwhich you experience as your skin looking more aged, Prof Bader shares.

Augustinus Baders The Cream is designed to target these traumas inflicted by everyday stressors by providing the cells with everything they need to help fix the things that go wrong. It does this with TFC8 complex, which replenishes key nutrients with a blend of natural amino acids, medical-grade vitamins, and synthesized molecules that are naturally found on the skin. The addition of antioxidant vitamins C and B5, as well as hydrolysed rice protein also helps to hydrate, condition and heal the skin.

Read more:
You Can Influence The Way Your Skin AgesHere's How - Tatler Singapore

The latest specialized intelligence report published by KandJ Market Research with the titleGlobal Skin Care Cosmetic Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)has the ability to help the decision-makers in the most important market in the world that has played a significantly important role in making a progressive impact on the global economy. The Global Multi-band Antenna Market Report presents and showcases a vital vision of the global scenario in terms of market size, market potentials, and competitive environment. The study is derivative from primary and secondary statistical data and consists of qualitative and quantitative analysis of the industry and key players.

The latest report includes Post Impact of Coronavirus(Covid-19) on the Skin Care Cosmetic Industry, it includes on Industry Upstream, Industry Downstream, Industry Channels, Industry Competition, and finally on Industry Employment.

Get Sample Copy of the Report Post COVID-19 ImpactClick Here ->http://www.kandjmarketresearch.com/sample-request/526547

The segmentation plays a prominent role in dealing with the growth of the Skin Care Cosmetic market where as severalSkin Care Cosmetic Industrytypes and applications are nurturing better understanding of the market. This segmentation has a solid foundation in volume-wise and value-wise data, which support the process of understanding the market scenario with numbers. The market has been explored through properly to get all the factors in line. TheSkin Care Cosmeticreport has been enhanced interviews as a direct strategy of getting information. These interviews include chats with top market players, market experts, suppliers, people in the field of research and development and others, due to which the reliability of the report has increased significantly.

Some of the prominent players operating in the global Skin Care Cosmetic market include:Beiersdorf AG, LOreal S.A., Unilever PLC, Procter & Gamble, Avon Products Inc, Johnson & Johnson, The Estee Lauder Companies Inc, Kao Corporation, The Body Shop International PLC

Skin Care Cosmetic Market Segmentation by Product Types:Sensitive Skin Care, Dry Skin Care, Infants Skin Care, Others

Skin Care Cosmetic Market Segmentation by Applications:Stem Cells Protection Against UV, Flakiness Reduction, Rehydrate the Skin Surface, Minimize wrinkles, Increase the viscosity of Aqueous

Read More Detailed Information regarding Skin Care Cosmetic Industry with latest updates @www.kandjmarketresearch.com/reports/526547

Regional market analysis of the report has supported the study of different regions as an endeavour to understand growth pockets that can be favourable for the market. The regional analysis has import, export, and other secured processes. Players who are engaging in the market for superior growth are looking for these growth pockets to capitalize on the provided opportunities and find new opportunities for growth. Certain countries have been followed in detail to monitor them carefully as they can be significant markets in the coming years. Benefits like better infrastructure, cost-effective labor, access to raw materials, they offer have become attracting factors for many players of the market and they want to expand their business to these regions to increase their profit margin or overall revenue.

Reasons to invest in this report:1. Complete analysis on market dynamics, market status, and competitive Skin Care Cosmetic view is offered.2. Forecast of Skin Care Cosmetic Industry trends will present the market drivers, constraints and growth opportunities.3. This research report will help to understand how the market will grow in the future years lets say next 5-6 years and so on.4. All dynamic Skin Care Cosmetic Industry verticals are existing in this study like Product Type, Applications and Geographical Regions.5. This in-depth market study will help to analyze and take informed decision in their respective field.

Ask Discount for this Premium Report @www.kandjmarketresearch.com/discount/526547

Customization of the Report:If you have any special requirements for the report, or customized report on separate regional or country-level, please connect with our sales team ([emailprotected]), who will ensure that you will get a report that suits your needs. You can also get in touch with our executives on+1-661-636-6162to share your research requirements.

About Us:Kandjmarketresearch.com is part of the KnowledgeNJournals Research Firm which provides premium progressive market research reports, statistical surveying, analysis & forecast data for industries and governments from hundreds of publishers around the world. We have almost all top publishers reports in our collection to provide you with instant online access to the worlds most complete and fresh database on a Daily Basis. We are at KandJ Market Research are inspired to help our clients grow by providing appropriate business insight with our huge market intelligence source.

For more details, contact at:Yash KandJ Market Research(Part of KnowledgeNJournals Research)USA: +1 (661) 636 6162 | IND: +91 9325802062 or

E-mail:[emailprotected]Website:https://www.kandjmarketresearch.com

Go here to read the rest:
Global Growth Trends and Competitive Analysis of Skin Care Cosmetic Research Report from 2020-2026 - KYT24

Of late, there has been an increasing awareness regarding the therapeutic potential of stem cells for management of diseases which is boosting the growth of the stem cell therapy market. The development of advanced genome based cell analysis techniques, identification of new stem cell lines, increasing investments in research and development as well as infrastructure development for the processing and banking of stem cell are encouraging the growth of the global stem cell therapy market.

Get Exclusive PDF Sample Copy Of This Report:https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1787

One of the key factors boosting the growth of this market is the limitations of traditional organ transplantation such as the risk of infection, rejection, and immunosuppression risk. Another drawback of conventional organ transplantation is that doctors have to depend on organ donors completely. All these issues can be eliminated, by the application of stem cell therapy. Another factor which is helping the growth in this market is the growing pipeline and development of drugs for emerging applications. Increased research studies aiming to widen the scope of stem cell will also fuel the growth of the market. Scientists are constantly engaged in trying to find out novel methods for creating human stem cells in response to the growing demand for stem cell production to be used for disease management.

It is estimated that the dermatology application will contribute significantly the growth of the global stem cell therapy market. This is because stem cell therapy can help decrease the after effects of general treatments for burns such as infections, scars, and adhesion. The increasing number of patients suffering from diabetes and growing cases of trauma surgery will fuel the adoption of stem cell therapy in the dermatology segment.

Global Stem Cell Therapy Market: Overview

Also called regenerative medicine, stem cell therapy encourages the reparative response of damaged, diseased, or dysfunctional tissue via the use of stem cells and their derivatives. Replacing the practice of organ transplantations, stem cell therapies have eliminated the dependence on availability of donors. Bone marrow transplant is perhaps the most commonly employed stem cell therapy.

Osteoarthritis, cerebral palsy, heart failure, multiple sclerosis and even hearing loss could be treated using stem cell therapies. Doctors have successfully performed stem cell transplants that significantly aid patients fight cancers such as leukemia and other blood-related diseases.

Buy This Report @https://www.tmrresearch.com/checkout?rep_id=1787<ype=S

Global Stem Cell Therapy Market: Key Trends

The key factors influencing the growth of the global stem cell therapy market are increasing funds in the development of new stem lines, the advent of advanced genomic procedures used in stem cell analysis, and greater emphasis on human embryonic stem cells. As the traditional organ transplantations are associated with limitations such as infection, rejection, and immunosuppression along with high reliance on organ donors, the demand for stem cell therapy is likely to soar. The growing deployment of stem cells in the treatment of wounds and damaged skin, scarring, and grafts is another prominent catalyst of the market.

On the contrary, inadequate infrastructural facilities coupled with ethical issues related to embryonic stem cells might impede the growth of the market. However, the ongoing research for the manipulation of stem cells from cord blood cells, bone marrow, and skin for the treatment of ailments including cardiovascular and diabetes will open up new doors for the advancement of the market.

Global Stem Cell Therapy Market: Market Potential

A number of new studies, research projects, and development of novel therapies have come forth in the global market for stem cell therapy. Several of these treatments are in the pipeline, while many others have received approvals by regulatory bodies.

In March 2017, Belgian biotech company TiGenix announced that its cardiac stem cell therapy, AlloCSC-01 has successfully reached its phase I/II with positive results. Subsequently, it has been approved by the U.S. FDA. If this therapy is well- received by the market, nearly 1.9 million AMI patients could be treated through this stem cell therapy.

Another significant development is the granting of a patent to Israel-based Kadimastem Ltd. for its novel stem-cell based technology to be used in the treatment of multiple sclerosis (MS) and other similar conditions of the nervous system. The companys technology used for producing supporting cells in the central nervous system, taken from human stem cells such as myelin-producing cells is also covered in the patent.

Global Stem Cell Therapy Market: Regional Outlook

The global market for stem cell therapy can be segmented into Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa. North America emerged as the leading regional market, triggered by the rising incidence of chronic health conditions and government support. Europe also displays significant growth potential, as the benefits of this therapy are increasingly acknowledged.

Asia Pacific is slated for maximum growth, thanks to the massive patient pool, bulk of investments in stem cell therapy projects, and the increasing recognition of growth opportunities in countries such as China, Japan, and India by the leading market players.

Global Stem Cell Therapy Market: Competitive Analysis

Several firms are adopting strategies such as mergers and acquisitions, collaborations, and partnerships, apart from product development with a view to attain a strong foothold in the global market for stem cell therapy.

Some of the major companies operating in the global market for stem cell therapy are RTI Surgical, Inc., MEDIPOST Co., Ltd., Osiris Therapeutics, Inc., NuVasive, Inc., Pharmicell Co., Ltd., Anterogen Co., Ltd., JCR Pharmaceuticals Co., Ltd., and Holostem Terapie Avanzate S.r.l.

To know more about the table of contents, you can click @https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1787

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to busi-ness entities keen on succeeding in todays supercharged economic climate. Armed with an experi-enced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

More here:
Stem Cell Therapy Market to Register Unwavering Growth During 2025 - The Think Curiouser

Fremont, CA , Oct. 28, 2020 (GLOBE NEWSWIRE) -- APstem Therapeutics, Inc., a private biopharmaceutical company developing breakthrough stem cell therapies, today announced the completion of an INitial Targeted Engagement for Regulatory Advice on CBER ProducTs (INTERACT) meeting with the U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT). The meeting, which included CBER OTAT staff together with the APstem team, focused on the development plan for AP-Skin-01, a novel off-the-shelf allogeneic stem cell product derived from adult pluripotent stem cells (APSCs) for the initial treatment of diabetic ulcers.

Previous efforts to treat diabetic ulcers have been hampered by persistent inflammation, ischemia and delayed re-epithelialization, which together have posed an insurmountable challenge for drug developers. APstems proprietary stem cell technologies and unique attributes of APSCs may circumvent these obstacles. Preclinical results generated to date by APstem support the potential of AP-Skin-01 to treat difficult-to-heal diabetic ulcers by accelerating healing. AP-Skin-01 is designed to provide full skin structural reconstruction with less scar formation, promote angiogenesis and reduce inflammation during the repair process.

The INTERACT meeting we conducted with the FDA is an important first step in our development of AP-Skin-01. We considered the meeting to be very successful, with productive feedback from the FDA reviewers and strong alignment of APstems development approach for AP-Skin-01, said Dr. Min Hu, CEO and president of APstem Therapeutics. I would like to thank the reviewers from FDA CBER OTAT for their time and helpful guidance. We look forward to continuing our planned pre-clinical work into 2021.

Dr. Jane Lebkowski, APstems scientific advisor and an expert in the development of cell and gene therapies, added: The field of chronic diabetic wounds remains a critical unmet medical need in the expanding diabetic population worldwide. This new therapy has high potential to accelerate full skin regeneration. Therefore, we are grateful for FDAs positive feedback to accelerate the development of this product that could treat millions of patients.

INTERACT is the first available FDA interaction and is a key step in the pathway towards an Investigational New Drug (IND) application, the first regulatory step before experimental therapies may be tested in human clinical studies.

About APstem Therapeutics, Inc.

APstem Therapeutics is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and commercializing novel stem cell therapies. APstems breakthrough stem cell therapy platform using our unique APSCs can be applied to multiple indications, including skin (diabetic ulcers), liver, lungs, bone/cartilage, heart, neuron and other tissues. For more information, please visit http://www.apstemtx.com.

Read the original here:
APstem Therapeutics Announces Successful FDA INTERACT Meeting Regarding AP-Skin-01, an Off-the-Shelf Allogeneic Stem Cell Product for the Treatment of...

Medical skin care products are used for beautifying or to address some other skin care problems. The cosmetic industry is booming and skin care forms a very huge part of this industry. The aesthetic appearance is so important that people spend a lot on skin care products and treatment. People being more technologically aware of the various new skin care products trending in the market. In addition to the aesthetic application, the medical skin care products are also used to address issues such as acne, pimples or scars.

Medical Skin Care Products Market: Drivers and Restraints

The medical skin care products is primarily driven by the need of natural based active ingredients products which are now trending in the market. Consumers demand medical skin care products which favor health and environment. Moreover, the consumers are updated with the trends so that various companies end up providing such products to satisfy the customers. For instance, a single product face mask has thousands of different variants. This offers consumers different options to select the product depending on the skin type. Moreover, the market players catering to the medical skin care products are offering products with advanced technologies. For instance, Santinov launched the CICABEL mask using stem cell material based on advanced technologies. The stem cells used in the skin care product helps to to protect and activate the cells and promote the proliferation of skin epidermal cells and the anagenesis of skin fibrosis.

To remain ahead of your competitors, request for a sample[emailprotected]

https://www.persistencemarketresearch.com/samples/18469

Medical Skin Care Products Market: Segmentation

On the basis of product type the medical skin care products market can be segmented as:

On the basis of application, the medical skin care products market can be segment as:

On the basis of distribution channel, the medical skin care products market can be segment as:

Medical Skin Care Products Market: Overview

Medical skin care products are used to address basic skin problems ranging from acne to scars. There are various advancements in the ingredients used to offer skin care products to the consumers. For instance, the use of hyaluronic acid and retinoids is the latest development in the industry. The anti-aging creams are at the forefront as the help treating issues such as wrinkles, scars, acne, and sun damage. Another, product in demand is the probiotic skincare which include lactobacillus and bifidobacterium.

To receive extensive list of important regions, Request Methodology here @

https://www.persistencemarketresearch.com/methodology/18469

Medical Skin Care Products Market: Region-wise Outlook

In terms of geography, medical skin care products market has been divided into five regions including North- America, Asia- Pacific, Middle-East & Africa, Latin America and Europe. North America dominated the global medical skin care products market as international players are acquiring domestic companies to make their hold strong in the U.S. LOral is accelerating its U.S. market by signing a definitive agreement with Valeant Pharmaceuticals International Inc. to acquire CeraVe, AcneFree and Ambi skin-care brands for US$ 1.3 billion. The acquisition is expected LOreal to get hold of the brands in the price-accessible segment. Asia Pacific is expected to be the fastest growing region owing to the increasing disposable income and rising awareness towards the skin care products.

Medical Skin Care Products Market: Key Market Participants

Some of the medical skin care products market participants are Avon Products Inc., Beiersdorf AG, Colgate-Palmolive Company, Kao Corporation, LOral S.A., Procter & Gamble, Shiseido Company, The Estee Lauder Companies Inc., Unilever PLC, Revlon, Clinique Laboratories, llc., Murad, LLC., SkinCeuticals, RMS Beauty, J.R. Watkins and 100% PURE.

You Can Request for TOC Here @https://www.persistencemarketresearch.com/toc/18469

Explore Extensive Coverage of PMR`s

Life Sciences & Transformational HealthLandscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Naved BegPersistence Market ResearchAddress 305 Broadway, 7th Floor, New York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Websitehttps://www.persistencemarketresearch.com

See the rest here:
The Medical Skin Care Products market to witness non-linear transition from 2017 to 2025 - Eurowire